Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Galati

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Atrial Fibrillation|December 14, 2016
CETP TaqIB Polymorphism, Serum Lipid Levels And Risk Of Atrial Fibrillation: A Case-Control StudyFrancesca Galati, Paolo Colonna, Antonio Galati, et al.
Diagnostics (Basel, Switzerland)|November 11, 2022
Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score<sup>®</sup> Test?Francesca Galati, Valentina Magri, Giuliana Moffa, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 10, 2024
Could breast multiparametric MRI discriminate between pure ductal carcinoma in situ and microinvasive carcinoma?Veronica Rizzo, Federica Cicciarelli, Francesca Galati, et al.
Diagnostics (Basel, Switzerland)|August 12, 2023
Diagnostic Performance of Contrast-Enhanced Digital Mammography versus Conventional Imaging in Women with Dense BreastsGiuliana Moffa, Francesca Galati, Roberto Maroncelli, et al.
Diagnostics (Basel, Switzerland)|December 18, 2020
Can MRI Biomarkers Predict Triple-Negative Breast Cancer?Giuliana Moffa, Francesca Galati, Emmanuel Collalunga, et al.
Frontiers in Oncology|October 10, 2022
Do body composition parameters correlate with response to targeted therapy in ER+/HER2- metastatic breast cancer patients? Role of sarcopenia and obesityEndi Kripa, Veronica Rizzo, Francesca Galati, et al.
Diagnostics (Basel, Switzerland)|June 19, 2024
Digital Mammography (DM) vs. Dynamic Contrast Enhancement-Magnetic Resonance Imaging (DCE-MRI) in Microcalcifications Assessment: A Radiological-Pathological ComparisonFederica Cicciarelli, Elisa Guiducci, Francesca Galati, et al.
Breast Care (Basel, Switzerland)|October 27, 2017
Added Value of Digital Breast Tomosynthesis Combined with Digital Mammography According to Reader Agreement: Changes in BI-RADS Rate and Follow-Up ManagementFrancesca Galati, Flaminia Marzocca, Erica Bassetti, et al.
La Radiologia Medica|November 13, 2024
BPE on contrast-enhanced mammography: relationship with breast density, age and menopausal statusGiuliana Moffa, Francesca Galati, Alessandra Spagnoli, et al.
European Radiology Experimental|August 7, 2022
Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?Francesca Galati, Veronica Rizzo, Giuliana Moffa, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Atrial Fibrillation|December 14, 2016
CETP TaqIB Polymorphism, Serum Lipid Levels And Risk Of Atrial Fibrillation: A Case-Control StudyFrancesca Galati, Paolo Colonna, Antonio Galati, et al.
Diagnostics (Basel, Switzerland)|November 11, 2022
Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score<sup>®</sup> Test?Francesca Galati, Valentina Magri, Giuliana Moffa, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 10, 2024
Could breast multiparametric MRI discriminate between pure ductal carcinoma in situ and microinvasive carcinoma?Veronica Rizzo, Federica Cicciarelli, Francesca Galati, et al.
Diagnostics (Basel, Switzerland)|August 12, 2023
Diagnostic Performance of Contrast-Enhanced Digital Mammography versus Conventional Imaging in Women with Dense BreastsGiuliana Moffa, Francesca Galati, Roberto Maroncelli, et al.
Diagnostics (Basel, Switzerland)|December 18, 2020
Can MRI Biomarkers Predict Triple-Negative Breast Cancer?Giuliana Moffa, Francesca Galati, Emmanuel Collalunga, et al.
Frontiers in Oncology|October 10, 2022
Do body composition parameters correlate with response to targeted therapy in ER+/HER2- metastatic breast cancer patients? Role of sarcopenia and obesityEndi Kripa, Veronica Rizzo, Francesca Galati, et al.
Diagnostics (Basel, Switzerland)|June 19, 2024
Digital Mammography (DM) vs. Dynamic Contrast Enhancement-Magnetic Resonance Imaging (DCE-MRI) in Microcalcifications Assessment: A Radiological-Pathological ComparisonFederica Cicciarelli, Elisa Guiducci, Francesca Galati, et al.
Breast Care (Basel, Switzerland)|October 27, 2017
Added Value of Digital Breast Tomosynthesis Combined with Digital Mammography According to Reader Agreement: Changes in BI-RADS Rate and Follow-Up ManagementFrancesca Galati, Flaminia Marzocca, Erica Bassetti, et al.
La Radiologia Medica|November 13, 2024
BPE on contrast-enhanced mammography: relationship with breast density, age and menopausal statusGiuliana Moffa, Francesca Galati, Alessandra Spagnoli, et al.
European Radiology Experimental|August 7, 2022
Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?Francesca Galati, Veronica Rizzo, Giuliana Moffa, et al.
Pageof 4